232 related articles for article (PubMed ID: 26679995)
21. HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.
Zhang F; Bieniasz PD
Elife; 2020 Jun; 9():. PubMed ID: 32538781
[TBL] [Abstract][Full Text] [Related]
22. Gene silencing in HIV-1 latency by polycomb repressive group.
Kim HG; Kim KC; Roh TY; Park J; Jung KM; Lee JS; Choi SY; Kim SS; Choi BS
Virol J; 2011 Apr; 8():179. PubMed ID: 21496352
[TBL] [Abstract][Full Text] [Related]
23. Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production.
Mashiba M; Collins DR; Terry VH; Collins KL
Cell Host Microbe; 2014 Dec; 16(6):722-35. PubMed ID: 25464830
[TBL] [Abstract][Full Text] [Related]
24. Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.
Zhao L; Wang S; Xu M; He Y; Zhang X; Xiong Y; Sun H; Ding H; Geng W; Shang H; Liang G
Nat Commun; 2021 Jun; 12(1):3691. PubMed ID: 34140527
[TBL] [Abstract][Full Text] [Related]
25. Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.
Pham TN; Richard J; Gerard FC; Power C; Cohen ÉA
J Virol; 2011 Dec; 85(23):12254-61. PubMed ID: 21957298
[TBL] [Abstract][Full Text] [Related]
26. Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications.
Das B; Dobrowolski C; Shahir AM; Feng Z; Yu X; Sha J; Bissada NF; Weinberg A; Karn J; Ye F
Virology; 2015 Jan; 474():65-81. PubMed ID: 25463605
[TBL] [Abstract][Full Text] [Related]
27. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
28. Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr.
Datta PK; Deshmane S; Khalili K; Merali S; Gordon JC; Fecchio C; Barrero CA
Cell Cycle; 2016 Sep; 15(17):2288-98. PubMed ID: 27245560
[TBL] [Abstract][Full Text] [Related]
29. Critical role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis.
Busca A; Saxena M; Kumar A
J Biol Chem; 2012 Apr; 287(18):15118-33. PubMed ID: 22403404
[TBL] [Abstract][Full Text] [Related]
30. A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression.
Keedy KS; Archin NM; Gates AT; Espeseth A; Hazuda DJ; Margolis DM
J Virol; 2009 May; 83(10):4749-56. PubMed ID: 19279091
[TBL] [Abstract][Full Text] [Related]
31. The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover.
Wen X; Casey Klockow L; Nekorchuk M; Sharifi HJ; de Noronha CM
PLoS One; 2012; 7(1):e30939. PubMed ID: 22292079
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.
Belzile JP; Duisit G; Rougeau N; Mercier J; Finzi A; Cohen EA
PLoS Pathog; 2007 Jul; 3(7):e85. PubMed ID: 17630831
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 Vpr Reprograms CLR4
Yan J; Shun MC; Hao C; Zhang Y; Qian J; Hrecka K; DeLucia M; Monnie C; Ahn J; Skowronski J
mBio; 2018 Oct; 9(5):. PubMed ID: 30352932
[TBL] [Abstract][Full Text] [Related]
34. Protein Arginine
Murakami H; Suzuki T; Tsuchiya K; Gatanaga H; Taura M; Kudo E; Okada S; Takei M; Kuroda K; Yamamoto T; Hagiwara K; Dohmae N; Aida Y
Viruses; 2020 Mar; 12(3):. PubMed ID: 32210193
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome.
Li G; Elder RT; Dubrovsky L; Liang D; Pushkarsky T; Chiu K; Fan T; Sire J; Bukrinsky M; Zhao RY
PLoS One; 2010 Jun; 5(6):e11371. PubMed ID: 20614012
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 Vpr redirects host ubiquitination pathway.
Arora S; Verma S; Banerjea AC
J Virol; 2014 Aug; 88(16):9141-52. PubMed ID: 24899191
[TBL] [Abstract][Full Text] [Related]
37. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
[TBL] [Abstract][Full Text] [Related]
38. Illuminating the Role of Vpr in HIV Infection of Myeloid Cells.
Nodder SB; Gummuluru S
Front Immunol; 2019; 10():1606. PubMed ID: 31396206
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 Vpr increases HCV replication through VprBP in cell culture.
Yan Y; Huang F; Yuan T; Sun B; Yang R
Virus Res; 2016 Sep; 223():153-60. PubMed ID: 27460548
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Vpr Induces Degradation of Gelsolin, a Myeloid Cell-Specific Host Factor That Reduces Viral Infectivity by Inhibiting the Expression and Packaging of the HIV-1 Env Glycoprotein.
Fabryova H; Kao S; Sukegawa S; Miyagi E; Taylor L; Ferhadian D; Saito H; Schaal H; Hillebrand F; Strebel K
mBio; 2023 Feb; 14(1):e0297322. PubMed ID: 36602307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
